Hinweis-Modus ist eingeschaltet Ausschalten

520700 - Wanjia CSI HKC Innovative Drug ETF (CNY) (CNE100006LT9)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
 
(%)
CNE100006LT9
520700 ISIN
Exchange Traded Funds (ETF)
Fondstyp
Wanjia Asset Management
Anbieter
-
NAV pro Aktie
13/09/2024
Startdatum
1 Wiederholungen pro Jahr
Ausschüttung von Dividenden
CMXXXX
CFI
520700
Ticker
Formed
Status
Equity
Investitionsobjekt
Healthcare
Sektor
Hong Kong
Geographie
CSI Hong Kong Stock Connect Innovative Drug Index
Benchmark
0.4 %
Gesamtkostenquote
Physical
Replikationsmethode
Nein
UCITS
Passive (Index)
Management Style

Letzte Daten zum
Zum Vergleichen hinzufügen

Kurse (520700)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

80 234

Aktien

167 970

ETF & Funds

80 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

  • Bond-Screener
  • Watchlist
  • Excel-Add-In

Kurs-Dynamik

Fund profile

The Wanjia CSI HKC Innovative Drug ETF seeks to replicate as closely as possible the price and yield performance of the CSI Hong Kong Stock Connect Innovative Drug Index by investing in a portfolio comprised primarily of Hong Kong companies

520700 profile

The Wanjia CSI HKC Innovative Drug ETF (CNY) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Hong Kong. The Wanjia Asset Management fund’s base currency is CNY and the share class was registered 13.09.2024 with unique ISIN - CNE100006LT9. Main exchange is Shanghai SE and ticker symbol is 520700. The total expense ratio is 0.4%. The Wanjia CSI HKC Innovative Drug ETF (CNY) pays dividends 1 time(s) per year.

Andere ETFs und Fonds dieses Anbieters

Ähnliche Etf & Fonds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} Mio.
    NAV
    {{ item.expense_ratio }}
    Gesamtkostenquote
Sie müssen sich registrieren , um Zugriff zu erhalten.